作者: Christopher J Pelham , Amit N Pandya , Devendra K Agrawal
DOI: 10.1517/13543776.2014.977865
关键词:
摘要: Introduction: Triggering receptor expressed on myeloid cells (TREM) receptors and TREM-like transcript (TLT; or TREML) of the immunoglobulin superfamily are known as key modulators host immune responses. TREM-1 (CD354) TREM-2 share transmembrane adaptor DNAX-activation protein 12 kDa (DAP12), but they possess separate stimulatory inhibitory functional roles, especially in cells.Areas covered: This review covers findings related to TREMs TLTs published patent applications from their discovery 2000 present. New roles for TREM-1, TREM-2, TLT-1 TLT-2 maladies ranging acute chronic inflammatory disorders cardiovascular diseases cancers discussed. Putative endogenous ligands novel synthetic peptide blockers also discussed.Expert opinion: So far, therapeutic use activators/blockers specific has been limited preclinical animal models. is an immediate target infl...